VTv Historical Income Statement
| VTVT Stock | USD 25.98 1.00 4.00% |
Historical analysis of VTv Therapeutics income statement accounts such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K, Selling General Administrative of 11.5 M or Total Revenue of 8.6 K can show how well vTv Therapeutics performed in making a profits. Evaluating VTv Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of VTv Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining vTv Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether vTv Therapeutics is a good buy for the upcoming year.
VTv |
About VTv Income Statement Analysis
vTv Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to VTv Therapeutics shareholders. The income statement also shows VTv investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
VTv Therapeutics Income Statement Chart
vTv Therapeutics Income Statement is one of the three primary financial statements used for reporting VTv's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of vTv Therapeutics revenue and expense. VTv Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, VTv Therapeutics' Other Operating Expenses is comparatively stable compared to the past year. Research Development is likely to gain to about 18 M in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts vTv Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of vTv Therapeutics. It is also known as VTv Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from VTv Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into vTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.At this time, VTv Therapeutics' Other Operating Expenses is comparatively stable compared to the past year. Research Development is likely to gain to about 18 M in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 25.7M | 24.6M | 25.4M | 26.4M | Cost Of Revenue | 89K | 92K | 90K | 85.5K |
VTv Therapeutics income statement Correlations
Click cells to compare fundamentals
VTv Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VTv Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 881K | (258K) | 4.1M | (2.3M) | 90K | 85.5K | |
| Interest Expense | 1.8M | 692K | 12K | 15K | 13K | 12.4K | |
| Selling General Administrative | 8.5M | 7.3M | 12.3M | 12.2M | 11.9M | 11.5M | |
| Total Revenue | 2.8M | 6.4M | 4.0M | 2.0M | 9K | 8.6K | |
| Gross Profit | (12.4M) | (4.6M) | 3.9M | 1.9M | (90K) | (85.5K) | |
| Other Operating Expenses | 23.7M | 18.3M | 25.7M | 24.6M | 25.5M | 26.4M | |
| Operating Income | (20.9M) | (11.9M) | (21.7M) | (22.5M) | (25.5M) | (26.8M) | |
| Ebit | (20.9M) | (11.9M) | (21.7M) | (22.5M) | (25.5M) | (26.8M) | |
| Research Development | 15.1M | 11.0M | 13.3M | 12.4M | 13.5M | 18.0M | |
| Ebitda | (20.0M) | (12.1M) | (17.6M) | (24.9M) | (25.4M) | (26.7M) | |
| Cost Of Revenue | 15.1M | 11.0M | 89K | 92K | 90K | 85.5K | |
| Total Operating Expenses | 23.7M | 18.3M | 25.7M | 24.6M | 25.4M | 26.4M | |
| Income Before Tax | (21.8M) | (12.8M) | (17.6M) | (24.9M) | (26.0M) | (27.3M) | |
| Total Other Income Expense Net | (946K) | (950K) | 4.0M | (2.3M) | (464K) | (487.2K) | |
| Net Income | (21.9M) | (8.8M) | (17.7M) | (25.1M) | (20.3M) | (21.3M) | |
| Income Tax Expense | 200K | 100K | (4.0M) | 115K | (5.7M) | (6.0M) | |
| Net Income From Continuing Ops | (21.9M) | (12.8M) | (17.7M) | (25.1M) | (27.6M) | (29.0M) | |
| Net Income Applicable To Common Shares | (17.9M) | (8.5M) | (13.0M) | (19.2M) | (22.0M) | (23.1M) | |
| Minority Interest | 40.2M | (4.3M) | 4.7M | (5.9M) | 6.1M | 5.8M | |
| Interest Income | 53K | 12K | 1K | 352K | 536K | 562.8K | |
| Net Interest Income | (1.8M) | (680K) | (11K) | 337K | 524K | 550.2K | |
| Reconciled Depreciation | 39K | 94K | 89K | 92K | 90K | 93.6K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VTv Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VTv Therapeutics' short interest history, or implied volatility extrapolated from VTv Therapeutics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.